Schorno Dean L Insider Trades

Insider Trading History

Track insider trading activity for Schorno Dean L. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
EVP & Chief Financial Officer
Holding Value $2.31M 76,337 shares
Last Trade
Feb 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$734k 20,636 shares
$35.55
$30.30
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
EVP & Chief Financial Officer
Holding Value $1.69M 55,701 shares
Last Trade
Feb 10, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$123k 3,546 shares
$34.62
$30.30
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
EVP & Chief Financial Officer
Holding Value $1.8M 59,247 shares
Last Trade
Feb 02, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$198k 5,488 shares
$36.01
$30.30
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
EVP & Chief Financial Officer
Holding Value $1.95M 64,235 shares
Last Trade
Dec 22, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$287k 6,500 shares
$44.16
$30.30
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
EVP & Chief Financial Officer
Holding Value $520k 17,153 shares
Last Trade
Dec 22, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$287k 6,500 shares
$44.16
$30.30
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
EVP & Chief Financial Officer
Holding Value $224k 7,394 shares
Last Trade
Sep 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$276k 7,394 shares
$37.30
$30.30
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
EVP & Chief Financial Officer
Holding Value $238k 7,850 shares
Last Trade
Mar 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$299k 13,475 shares
$22.18
$30.30
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
EVP & Chief Financial Officer
Holding Value $1.73M 57,235 shares
Last Trade
Feb 05, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$38k 1,734 shares
$21.93
$30.30
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
EVP & Chief Financial Officer
Holding Value $1.79M 58,969 shares
Last Trade
Feb 04, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$42.6k 2,036 shares
$20.92
$30.30
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
EVP & Chief Financial Officer
Holding Value $1.85M 61,005 shares
Last Trade
Jan 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$333k 14,788 shares
$22.49
$30.30
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
EVP & Chief Financial Officer
Holding Value $189k 6,250 shares
Last Trade
Nov 25, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$163k 6,250 shares
$26.09
$30.30
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
EVP & Chief Financial Officer
Holding Value $303k 10,000 shares
Last Trade
Aug 30, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$134k 10,000 shares
$13.44
$30.30
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
EVP & Chief Financial Officer
Holding Value $2.38M 78,500 shares
Last Trade
Feb 28, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.19M 141,000 shares
$15.50
$30.30
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
EVP & Chief Financial Officer
Holding Value $12.2M 402,891 shares
Last Trade
Feb 05, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$82.2k 7,027 shares
$11.70
$30.30
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
EVP & Chief Financial Officer
Holding Value $12.4M 409,918 shares
Last Trade
Feb 02, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$63.9k 5,601 shares
$11.40
$30.30
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
EVP & Chief Financial Officer
Holding Value $12.6M 415,519 shares
Last Trade
Jan 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.99M 157,000 shares
$12.70
$30.30
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
EVP & Chief Financial Officer
Holding Value $5.95M 196,519 shares
Last Trade
Feb 02, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$95.4k 5,389 shares
$17.70
$30.30
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Director, EVP & Chief Financial Officer
Holding Value $6.12M 201,908 shares
Last Trade
Jan 26, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.27M 175,000 shares
$18.70
$30.30
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Director, EVP & Chief Financial Officer
Holding Value $1.52M 50,000 shares
Last Trade
Dec 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$655k 50,000 shares
$13.10
$30.30
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
EVP & Chief Financial Officer
Holding Value $2.46M 81,250 shares
Last Trade
Sep 14, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.04M 81,250 shares
$12.80
$30.30

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up